Huang et al. found that in mice and bladder cancer cells induced by N-butyl-N-(4-hydroxybutyl) nitrosamine, sulforaphane can down-regulate the protein and gene expression of HK II, PKM2, and PDH, as well as inhibit the expression of AKT1. Here, AKT1 is linked to urinary bladder carcinoma.